Gotham Asset Management LLC Purchases 16,765 Shares of Ingevity Co. (NYSE:NGVT)

Gotham Asset Management LLC boosted its holdings in shares of Ingevity Co. (NYSE:NGVT - Free Report) by 133.0% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 29,369 shares of the company's stock after acquiring an additional 16,765 shares during the period. Gotham Asset Management LLC owned 0.08% of Ingevity worth $1,197,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Maple Rock Capital Partners Inc. acquired a new position in shares of Ingevity in the 4th quarter valued at $17,515,000. American Century Companies Inc. grew its holdings in shares of Ingevity by 37.7% in the 4th quarter. American Century Companies Inc. now owns 1,457,365 shares of the company's stock valued at $59,388,000 after buying an additional 398,800 shares during the period. Royce & Associates LP grew its holdings in shares of Ingevity by 22.4% in the 4th quarter. Royce & Associates LP now owns 1,142,598 shares of the company's stock valued at $46,561,000 after buying an additional 208,921 shares during the period. Brown Advisory Inc. grew its holdings in shares of Ingevity by 23.6% in the 4th quarter. Brown Advisory Inc. now owns 928,220 shares of the company's stock valued at $37,825,000 after buying an additional 177,289 shares during the period. Finally, KLP Kapitalforvaltning AS acquired a new position in shares of Ingevity in the 4th quarter valued at $4,882,000. Institutional investors and hedge funds own 91.59% of the company's stock.

Ingevity Stock Down 3.6%

NGVT traded down $1.52 during trading on Wednesday, hitting $41.06. The company had a trading volume of 309,512 shares, compared to its average volume of 280,771. The firm's 50-day moving average price is $37.12 and its 200 day moving average price is $42.17. The company has a quick ratio of 1.04, a current ratio of 1.87 and a debt-to-equity ratio of 6.86. Ingevity Co. has a one year low of $28.49 and a one year high of $51.67. The company has a market capitalization of $1.50 billion, a PE ratio of -3.47 and a beta of 1.31.

Ingevity (NYSE:NGVT - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.99 EPS for the quarter, topping the consensus estimate of $0.74 by $0.25. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. The firm had revenue of $284.00 million for the quarter, compared to analysts' expectations of $299.13 million. During the same period in the previous year, the firm posted $0.47 EPS. The company's revenue for the quarter was down 16.5% on a year-over-year basis. As a group, equities analysts expect that Ingevity Co. will post 4.45 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms recently commented on NGVT. Wells Fargo & Company boosted their price objective on shares of Ingevity from $32.00 to $38.00 and gave the company an "equal weight" rating in a research report on Wednesday, May 7th. BMO Capital Markets raised shares of Ingevity from a "market perform" rating to an "outperform" rating and boosted their price objective for the company from $62.00 to $65.00 in a research report on Wednesday, February 26th. Finally, StockNews.com cut shares of Ingevity from a "buy" rating to a "hold" rating in a research report on Saturday, April 12th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Ingevity has an average rating of "Moderate Buy" and an average target price of $52.75.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.